<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Renin Angiotensin Aldosterone Syst</journal-id><journal-id journal-id-type="iso-abbrev">J Renin Angiotensin Aldosterone Syst</journal-id><journal-id journal-id-type="publisher-id">JRA</journal-id><journal-id journal-id-type="hwp">spjra</journal-id><journal-title-group><journal-title>Journal of the Renin-Angiotensin-Aldosterone System: JRAAS</journal-title></journal-title-group><issn pub-type="ppub">1470-3203</issn><issn pub-type="epub">1752-8976</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>Sage UK: London, England</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5843878</article-id><article-id pub-id-type="pmid">27296394</article-id><article-id pub-id-type="doi">10.1177/1470320316653283</article-id><article-id pub-id-type="publisher-id">10.1177_1470320316653283</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>No association of <italic>adiponectin</italic> +45 T/G polymorphism with the risk of gestational diabetes mellitus: Evidence from a meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Fang</given-names></name><xref ref-type="aff" rid="aff1-1470320316653283">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Hua</given-names></name><xref ref-type="aff" rid="aff2-1470320316653283">2</xref></contrib><contrib contrib-type="author"><name><surname>Qi</surname><given-names>Hongbo</given-names></name><xref ref-type="aff" rid="aff2-1470320316653283">2</xref><xref ref-type="corresp" rid="corresp1-1470320316653283"/></contrib></contrib-group><aff id="aff1-1470320316653283"><label>1</label>Department of Emergency, The First Affiliated Hospital of Chongqing Medical University, China</aff><aff id="aff2-1470320316653283"><label>2</label>Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, China</aff><author-notes><corresp id="corresp1-1470320316653283">Hongbo Qi, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. Email: <email>qihongbuedu@sina.com</email></corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>6</month><year>2016</year></pub-date><pub-date pub-type="collection"><season>Apr-Jun</season><year>2016</year></pub-date><volume>17</volume><issue>2</issue><elocation-id>1470320316653283</elocation-id><history><date date-type="received"><day>20</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>10</day><month>5</month><year>2016</year></date></history><permissions><copyright-statement>&#169; The Author(s) 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder content-type="sage">SAGE Publications</copyright-holder><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (<ext-link ext-link-type="uri" xlink:href="http://www.creativecommons.org/licenses/by-nc/3.0/">http://www.creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><abstract><sec id="section1-1470320316653283"><title>Introduction:</title><p>Adiponectin (<italic>ADIPOQ</italic>), involved in regulating glucose levels and fatty acid oxidation, plays key roles in metabolic derangements such as gestational diabetes mellitus (GDM). Previously, several studies have been conducted to assess the association between <italic>ADIPOQ</italic> +45 T/G polymorphism and risk of GDM. The results, however, are inconclusive. We aimed to evaluate the effect of the polymorphism on the risk of GDM using a meta-analysis.</p></sec><sec id="section2-1470320316653283"><title>Materials and methods:</title><p>After databases searching, eight records were identified. Pooled odds ratios (ORs) with their corresponding 95% confidence intervals (CIs) were used to evaluate the association between <italic>ADIPOQ</italic> +45 T/G polymorphism and risk of GDM.</p></sec><sec id="section3-1470320316653283"><title>Results:</title><p>No significant association was observed between the <italic>ADIPOQ</italic> +45 T/G polymorphism and the risk of GDM (heterozygote comparison: OR = 1.15, 95% CI, 0.70&#8211;1.89; homozygote comparison: OR = 1.21, 95% CI, 0.48&#8211;3.03; dominant model: OR = 0.86, 95% CI, 0.50&#8211;1.48, recessive model: OR = 1.21, 95% CI, 0.62&#8211;2.33, and allele comparison: OR = 1.17, 95% CI, 0.79&#8211;1.76, respectively). Apparent heterogeneity was detected. However, no evidence of publication bias was found.</p></sec><sec id="section4-1470320316653283"><title>Conclusions:</title><p>This meta-analysis provides evidence that the <italic>ADIPOQ</italic> +45 T/G polymorphism was not related to the risk of GDM. Further multicenter, prospective studies with larger sample size would be valuable to confirm the result.</p></sec></abstract><kwd-group><kwd>Gestational diabetes mellitus</kwd><kwd>adiponectin</kwd><kwd>polymorphism</kwd><kwd>meta-analysis</kwd><kwd>susceptibility</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>April-June 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="section5-1470320316653283"><title>Introduction</title><p>Gestational diabetes mellitus (GDM), characterized as glucose intolerance firstly occurring or recognized during pregnancy, is an important public health problem worldwide.<sup><xref rid="bibr1-1470320316653283" ref-type="bibr">1</xref>,<xref rid="bibr2-1470320316653283" ref-type="bibr">2</xref></sup> In China, the incidence increased during 1999&#8211;2013, from 2.4% to 12.1%.<sup><xref rid="bibr3-1470320316653283" ref-type="bibr">3</xref>,<xref rid="bibr4-1470320316653283" ref-type="bibr">4</xref></sup> Women with GDM possess high risks of adverse pregnancy outcomes and several maternal and perinatal complications, including neonatal hypoglycemia and adiposity, metabolic syndrome and future diabetes mellitus.<sup><xref rid="bibr5-1470320316653283" ref-type="bibr">5</xref><xref rid="bibr6-1470320316653283" ref-type="bibr"/><xref rid="bibr7-1470320316653283" ref-type="bibr"/><xref rid="bibr8-1470320316653283" ref-type="bibr"/>&#8211;<xref rid="bibr9-1470320316653283" ref-type="bibr">9</xref></sup> Regarding risk factors for GDM, several environmental triggers have been identified so far, such as obesity, poor diet and physical inactivity.<sup><xref rid="bibr10-1470320316653283" ref-type="bibr">10</xref><xref rid="bibr11-1470320316653283" ref-type="bibr"/>&#8211;<xref rid="bibr12-1470320316653283" ref-type="bibr">12</xref></sup> In addition, genetic components have also been reported to contribute to the development of GDM.<sup><xref rid="bibr13-1470320316653283" ref-type="bibr">13</xref><xref rid="bibr14-1470320316653283" ref-type="bibr"/>&#8211;<xref rid="bibr15-1470320316653283" ref-type="bibr">15</xref></sup></p><p>Adiponectin (<italic>ADIPOQ</italic>) is a protein hormone involved in regulating glucose levels and fatty acid oxidation.<sup><xref rid="bibr16-1470320316653283" ref-type="bibr">16</xref>,<xref rid="bibr17-1470320316653283" ref-type="bibr">17</xref></sup> The hormone plays a key role in the metabolic derangements that may lead to type 2 diabetes, atherosclerosis, obesity, metabolic syndrome and insulin resistance.<sup><xref rid="bibr16-1470320316653283" ref-type="bibr">16</xref>,<xref rid="bibr18-1470320316653283" ref-type="bibr">18</xref><xref rid="bibr19-1470320316653283" ref-type="bibr"/>&#8211;<xref rid="bibr20-1470320316653283" ref-type="bibr">20</xref></sup> The <italic>ADIPOQ</italic> gene, located on chromosome 3q27 in humans, contains three exons. A single nucleotide polymorphism (SNP) in exon 2 of <italic>ADIPOQ</italic> (+45 T/G, rs2241766) may influence the protein expression by affecting RNA splicing and stability.<sup><xref rid="bibr21-1470320316653283" ref-type="bibr">21</xref></sup> The SNP has been shown to be related to type 2 diabetes and insulin resistance.<sup><xref rid="bibr22-1470320316653283" ref-type="bibr">22</xref><xref rid="bibr23-1470320316653283" ref-type="bibr"/>&#8211;<xref rid="bibr24-1470320316653283" ref-type="bibr">24</xref></sup></p><p>Given the potential role of the <italic>ADIPOQ</italic> +45 T/G polymorphism in diabetes, several association studies have been conducted to assess the association between the polymorphism and risk of GDM.<sup><xref rid="bibr25-1470320316653283" ref-type="bibr">25</xref><xref rid="bibr26-1470320316653283" ref-type="bibr"/><xref rid="bibr27-1470320316653283" ref-type="bibr"/><xref rid="bibr28-1470320316653283" ref-type="bibr"/><xref rid="bibr29-1470320316653283" ref-type="bibr"/><xref rid="bibr30-1470320316653283" ref-type="bibr"/><xref rid="bibr31-1470320316653283" ref-type="bibr"/>&#8211;<xref rid="bibr32-1470320316653283" ref-type="bibr">32</xref></sup> The results, however, are inconsistent and inconclusive. For example, Takhshid et al. reported that the TG/GG genotypes had a 2.55-fold increased risk of GDM compared with the TT genotype,<sup><xref rid="bibr31-1470320316653283" ref-type="bibr">31</xref></sup> whereas Beltcheva et al. reported that no association with GDM was found for the polymorphism.<sup><xref rid="bibr25-1470320316653283" ref-type="bibr">25</xref></sup> One reason for the conflicting results is small samples in a single study. Meta-analysis is a useful tool to increase power by pooling all the published data together. In this study, we performed a meta-analysis to clarify whether the <italic>ADIPOQ</italic> +45 T/G polymorphism is associated with the risk of GDM.</p></sec><sec sec-type="materials|methods" id="section6-1470320316653283"><title>Materials and methods</title><sec id="section7-1470320316653283"><title>Records selection</title><p>PubMed, China National Knowledge Infrastructure, Weipu and Wangfang databases were searched using the following terms: &#8220;ADIPOQ or adiponectin&#8221; and &#8220;polymorphism* or variant&#8221; and &#8220;gestational diabetes mellitus&#8221; or &#8220;Gestational diabetes&#8221; (last search update October 30, 2015). Forty-one articles were identified after database searching. We selected publications using the following criteria: (a) studies evaluating the association between <italic>ADIPOQ</italic> +45 T/G polymorphism and the risk of GDM; (b) original genotyping data to compute pooled odds ratios (ORs) and 95% confidence interval (CI); (c) language was not restricted. Among them, 18 articles were removed for duplicate publication. After full-text assessment, 12 articles were excluded for these reasons: no <italic>ADIPOQ</italic> +45 T/G polymorphism (<italic>n</italic> = 8), reviews (<italic>n</italic> = 3), and not a study of GDM (<italic>n</italic> = 1). During data collection, we excluded three articles for repeated data. Finally, eight studies were included in this meta-analysis. A flow diagram of studies selection is presented in <xref ref-type="fig" rid="fig1-1470320316653283">Figure 1</xref>.</p><fig id="fig1-1470320316653283" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Flow diagram of studies selection.</p></caption><graphic xlink:href="10.1177_1470320316653283-fig1"/></fig></sec><sec id="section8-1470320316653283"><title>Data extraction</title><p>The following information was extracted by two researchers independently: author, year of publication, country (origin), ethnicity, study design, number of cases and controls, matching criteria, genotyping method, and minor allele frequency in controls. The information was checked by a third researcher to confirm the accuracy.</p></sec><sec id="section9-1470320316653283"><title>Statistical analysis</title><p>The association between the <italic>ADIPOQ</italic> +45 T/G polymorphism and the risk of GDM was evaluated by pooled ORs and their 95% CI under a heterozygote comparison, homozygote comparison, dominant model, recessive model, and allele comparison. A fixed-effects model was used to estimate summary ORs because <italic>p</italic> values for heterogeneity test were &#10877; 0.10 in all comparison analyses.<sup><xref rid="bibr33-1470320316653283" ref-type="bibr">33</xref></sup> To identify the sources of heterogeneity, subgroup analyses were performed based on the Hardy-Weinberg equilibrium (HWE) and sample size (&gt;100 vs. &#10877;100). Logistic meta-regression was also performed according to ethnicity, genotyping methods, HWE, and sample size. Begg&#8217;s funnel plot was used to test publication bias.<sup><xref rid="bibr34-1470320316653283" ref-type="bibr">34</xref></sup> All analyses were conducted using STATA software (version 10.0, STATA Corporation, College Station, TX, USA).</p></sec></sec><sec sec-type="results" id="section10-1470320316653283"><title>Results</title><sec id="section11-1470320316653283"><title>Characteristics of studies</title><p>The characteristics of the included studies are shown in <xref ref-type="table" rid="table1-1470320316653283">Table 1</xref>. In total, eight studies were included in this meta-analysis with 875 cases and 884 controls. Among them, seven studies were of Asian descendants<sup><xref rid="bibr26-1470320316653283" ref-type="bibr">26</xref><xref rid="bibr27-1470320316653283" ref-type="bibr"/><xref rid="bibr28-1470320316653283" ref-type="bibr"/><xref rid="bibr29-1470320316653283" ref-type="bibr"/><xref rid="bibr30-1470320316653283" ref-type="bibr"/><xref rid="bibr31-1470320316653283" ref-type="bibr"/>&#8211;<xref rid="bibr32-1470320316653283" ref-type="bibr">32</xref></sup> and one study was of European descendants.<sup><xref rid="bibr25-1470320316653283" ref-type="bibr">25</xref></sup> The sample sizes were relatively small in all the studies, with the least having 79 participants<sup><xref rid="bibr30-1470320316653283" ref-type="bibr">30</xref></sup> and the most having 436 participants.<sup><xref rid="bibr28-1470320316653283" ref-type="bibr">28</xref></sup> Most of the studies (62.5%) reported a matched frequency of controls to cases.<sup><xref rid="bibr25-1470320316653283" ref-type="bibr">25</xref>,<xref rid="bibr27-1470320316653283" ref-type="bibr">27</xref>,<xref rid="bibr29-1470320316653283" ref-type="bibr">29</xref>,<xref rid="bibr31-1470320316653283" ref-type="bibr">31</xref>,<xref rid="bibr32-1470320316653283" ref-type="bibr">32</xref></sup> Several genotyping methods were used, including TaqMan, polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), and DNA sequencing. However, only two studies reported quality control to ensure the reproducibility of the genotyping assay.<sup><xref rid="bibr25-1470320316653283" ref-type="bibr">25</xref>,<xref rid="bibr31-1470320316653283" ref-type="bibr">31</xref></sup> Most of the studies (75.0%) were consistent with HWE except for one study departing from HWE<sup><xref rid="bibr27-1470320316653283" ref-type="bibr">27</xref></sup> and one study without available data to assess HWE.<sup><xref rid="bibr25-1470320316653283" ref-type="bibr">25</xref></sup> Minor allele frequency in controls varied greatly, ranging from 0.10 to 0.49.</p><table-wrap id="table1-1470320316653283" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Characteristics of studies included in this meta-analysis.</p></caption><alternatives><graphic xlink:href="10.1177_1470320316653283-table1"/></alternatives><table-wrap-foot><fn id="table-fn1-1470320316653283"><p>MAF: minor allele frequency; PCR-RFLP: polymerase chain reaction-restriction fragment length polymorphism; BMI: body mass index.</p></fn></table-wrap-foot></table-wrap></sec><sec id="section12-1470320316653283"><title>Meta-analysis</title><p>As shown in <xref ref-type="table" rid="table2-1470320316653283">Table 2</xref>, no significant association was observed between the <italic>ADIPOQ</italic> +45 T/G polymorphism and the risk of GDM (heterozygote comparison: OR = 1.15, 95% CI, 0.70&#8211;1.89; homozygote comparison: OR = 1.21, 95% CI, 0.48&#8211;3.03; dominant model: OR = 0.86, 95% CI, 0.50&#8211;1.48, recessive model: OR = 1.21, 95% CI, 0.62&#8211;2.33, and allele comparison: OR = 1.17, 95% CI, 0.79&#8211;1.76, respectively) (<xref ref-type="fig" rid="fig2-1470320316653283">Figure 2</xref>). After excluding two studies with Hardy-Weinberg disequilibrium, no significant association was found. Additionally, we performed subgroup analysis according to sample size (&gt; 100 and &#10877;100); negative results were also observed in both subgroups.</p><table-wrap id="table2-1470320316653283" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Meta-analysis of the <italic>ADIPOQ</italic> +45 T/G polymorphism with the risk of gestational diabetes mellitus.</p></caption><alternatives><graphic xlink:href="10.1177_1470320316653283-table2"/></alternatives><table-wrap-foot><fn id="table-fn2-1470320316653283"><p>ADIPOQ: adiponectin; OR: odds ratio; CI: confidence interval; HWE: Hardy-Weinberg equilibrium.</p></fn><fn id="table-fn3-1470320316653283"><label>a</label><p>Random-effects model was used.</p></fn><fn id="table-fn4-1470320316653283"><label>b</label><p><italic>P</italic> value for heterogeneity test.</p></fn></table-wrap-foot></table-wrap><fig id="fig2-1470320316653283" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Meta-analysis of the <italic>ADIPOQ</italic> +45 T/G polymorphism with the risk of gestational diabetes mellitus (G vs. T). The random-effects model was used.</p></caption><graphic xlink:href="10.1177_1470320316653283-fig2"/></fig><sec id="section13-1470320316653283"><title>Heterogeneity analysis and publication bias</title><p>In overall and subgroup analyses, we detected apparent heterogeneity (<italic>p</italic> &#10877; 0.10). Logistic meta-regression was used to explore the sources of heterogeneity. We took the common variables influencing heterogeneity into consideration: ethnicity, genotyping methods, HWE, and sample size. However, none of these factors affected the heterogeneity among studies.</p><p>Begg&#8217;s funnel plot was used to test publication bias, and no evidence of publication bias was found (<italic>p</italic> &gt; 0.05) in the meta-analysis (<xref ref-type="fig" rid="fig3-1470320316653283">Figure 3</xref>).</p><fig id="fig3-1470320316653283" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Begg&#8217;s funnel plot for testing publication bias. Each circle indicates a separate study. (a) TG vs. TT; (b) GG vs. TT; (c) dominant model; (d) recessive model. OR: odds ratio.</p></caption><graphic xlink:href="10.1177_1470320316653283-fig3"/></fig></sec></sec></sec><sec sec-type="discussion" id="section14-1470320316653283"><title>Discussion</title><p>To the best of our knowledge, this is the first meta-analysis to investigate the relationship of the <italic>ADIPOQ</italic> +45 T/G polymorphism with GDM. We failed to find any association between the SNP and the risk of GDM, suggesting that the <italic>ADIPOQ</italic> +45 T/G polymorphism may not be a risk factor for the etiology of GDM.</p><p>Previously, several SNPs have been performed to evaluate the association with GDM, such as rs2241766 (Gly15Gly, +45 T/G) in exon 2, rs266729 (&#8722;11377 C/G) and rs17300539 (&#8722;11391G/A) in the promoter region, and rs1501299 (+276 G/T) in intron 2.<sup><xref rid="bibr25-1470320316653283" ref-type="bibr">25</xref><xref rid="bibr26-1470320316653283" ref-type="bibr"/><xref rid="bibr27-1470320316653283" ref-type="bibr"/><xref rid="bibr28-1470320316653283" ref-type="bibr"/><xref rid="bibr29-1470320316653283" ref-type="bibr"/><xref rid="bibr30-1470320316653283" ref-type="bibr"/><xref rid="bibr31-1470320316653283" ref-type="bibr"/>&#8211;<xref rid="bibr32-1470320316653283" ref-type="bibr">32</xref></sup> Among them, the <italic>ADIPOQ</italic> +45 T/G polymorphism is the most frequently investigated. Controversial results, however, have been obtained. In this study, we collected all previous publications and performed a meta-analysis to assess the association of the <italic>ADIPOQ</italic> +45 T/G polymorphism with the risk of GDM. Our meta-analysis provided evidence that the polymorphism was not a risk factor for the development of GDM although 75% (six of eight) studies reported a positive result.<sup><xref rid="bibr26-1470320316653283" ref-type="bibr">26</xref>,<xref rid="bibr27-1470320316653283" ref-type="bibr">27</xref>,<xref rid="bibr29-1470320316653283" ref-type="bibr">29</xref><xref rid="bibr30-1470320316653283" ref-type="bibr"/><xref rid="bibr31-1470320316653283" ref-type="bibr"/>&#8211;<xref rid="bibr32-1470320316653283" ref-type="bibr">32</xref></sup> After subgroup analysis according to HWE and sample size, null results were also observed.</p><p>Obvious heterogeneity was detected among studies. We used logistic meta-regression to examine the sources of heterogeneity based on ethnicity, genotyping methods, HWE, and sample size. None of these parameters could explain the heterogeneity, indicating that other unknown reasons may influence the heterogeneity. As most of the studies previously reported a significant association between the <italic>ADIPOQ</italic> +45 T/G polymorphism and susceptibility for GDM, in this meta-analysis we used Begg&#8217;s funnel plot to test if there is a tendency of prior publication positive results. However, no evidence of publication bias was found.</p><p>These are some limitations in this study. Firstly, sample size is very small in each single study as well as in this meta-analysis, which may result in false-negative result due to insufficient power. Secondly, very limited data in the literature reported the association between the <italic>ADIPOQ</italic> +45 T/G polymorphism and serum adiponectin level, which prevented further genotype-phenotype analysis. Thirdly, nearly all the studies included in this meta-analysis were of Asian descendants, and thus the results cannot be directly extended to other ethnicities. Further evaluation is warranted, especially in multi-ethnic populations.</p><p>In conclusion, this meta-analysis provides evidence that the <italic>ADIPOQ</italic> +45 T/G polymorphism was not related to the risk of GDM. Further multicenter, prospective studies with larger sample size would be of great value to confirm the result. Additionally, gene-gene and genotype-phenotype analysis may help to comprehensively understand the role of the SNP in the etiology of GDM.</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p><bold>Declaration of conflicting interests:</bold> The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was funded by the National Natural Science Foundation of China (grant number 81520108013).</p></fn></fn-group><ref-list><title>References</title><ref id="bibr1-1470320316653283"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Landon</surname><given-names>MB</given-names></name><name><surname>Spong</surname><given-names>CY</given-names></name><name><surname>Thom</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>A multicenter, randomized trial of treatment for mild gestational diabetes</article-title>. <source>N Engl J Med</source>
<year>2009</year>; <volume>361</volume>: <fpage>1339</fpage>&#8211;<lpage>1348</lpage>.<pub-id pub-id-type="pmid">19797280</pub-id></mixed-citation></ref><ref id="bibr2-1470320316653283"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reece</surname><given-names>EA</given-names></name><name><surname>Leguizamon</surname><given-names>G</given-names></name><name><surname>Wiznitzer</surname><given-names>A</given-names></name></person-group>
<article-title>Gestational diabetes: The need for a common ground</article-title>. <source>Lancet</source>
<year>2009</year>; <volume>373</volume>: <fpage>1789</fpage>&#8211;<lpage>1797</lpage>.<pub-id pub-id-type="pmid">19465234</pub-id></mixed-citation></ref><ref id="bibr3-1470320316653283"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Dong</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>CP</given-names></name><etal/></person-group>
<article-title>Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008</article-title>. <source>Diabet Med</source>
<year>2011</year>; <volume>28</volume>: <fpage>652</fpage>&#8211;<lpage>657</lpage>.<pub-id pub-id-type="pmid">21569085</pub-id></mixed-citation></ref><ref id="bibr4-1470320316653283"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhu</surname><given-names>WW</given-names></name><name><surname>Fan</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>HX</given-names></name><etal/></person-group>
<article-title>Fasting plasma glucose at 24&#8211;28 weeks to screen for gestational diabetes mellitus: New evidence from China</article-title>. <source>Diabetes Care</source>
<year>2013</year>; <volume>36</volume>: <fpage>2038</fpage>&#8211;<lpage>2040</lpage>.<pub-id pub-id-type="pmid">23536582</pub-id></mixed-citation></ref><ref id="bibr5-1470320316653283"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wendland</surname><given-names>EM</given-names></name><name><surname>Torloni</surname><given-names>MR</given-names></name><name><surname>Falavigna</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Gestational diabetes and pregnancy outcomes&#8212;a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria</article-title>. <source>BMC Pregnancy Childbirth</source>
<year>2012</year>; <volume>12</volume>: <fpage>23</fpage>.<pub-id pub-id-type="pmid">22462760</pub-id></mixed-citation></ref><ref id="bibr6-1470320316653283"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Retnakaran</surname><given-names>R</given-names></name><name><surname>Qi</surname><given-names>Y</given-names></name><name><surname>Sermer</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes</article-title>. <source>Diabetes Care</source>
<year>2008</year>; <volume>31</volume>: <fpage>2026</fpage>&#8211;<lpage>2031</lpage>.<pub-id pub-id-type="pmid">18628572</pub-id></mixed-citation></ref><ref id="bibr7-1470320316653283"><label>7</label><mixed-citation publication-type="journal">
<collab>HAPO Study Cooperative Research Group</collab>, <person-group person-group-type="author"><name><surname>Metzger</surname><given-names>BE</given-names></name><name><surname>Lowe</surname><given-names>LP</given-names></name><etal/></person-group>
<article-title>Hyperglycemia and adverse pregnancy outcomes</article-title>. <source>N Engl J Med</source>
<year>2008</year>; <volume>358</volume>: <fpage>1991</fpage>&#8211;<lpage>2002</lpage>.<pub-id pub-id-type="pmid">18463375</pub-id></mixed-citation></ref><ref id="bibr8-1470320316653283"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kubo</surname><given-names>A</given-names></name><name><surname>Ferrara</surname><given-names>A</given-names></name><name><surname>Windham</surname><given-names>GC</given-names></name><etal/></person-group>
<article-title>Maternal hyperglycemia during pregnancy predicts adiposity of the offspring</article-title>. <source>Diabetes Care</source>
<year>2014</year>; <volume>37</volume>: <fpage>2996</fpage>&#8211;<lpage>3002</lpage>.<pub-id pub-id-type="pmid">25150158</pub-id></mixed-citation></ref><ref id="bibr9-1470320316653283"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bellamy</surname><given-names>L</given-names></name><name><surname>Casas</surname><given-names>JP</given-names></name><name><surname>Hingorani</surname><given-names>AD</given-names></name><etal/></person-group>
<article-title>Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis</article-title>. <source>Lancet</source>
<year>2009</year>; <volume>373</volume>: <fpage>1773</fpage>&#8211;<lpage>1779</lpage>.<pub-id pub-id-type="pmid">19465232</pub-id></mixed-citation></ref><ref id="bibr10-1470320316653283"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ben-Haroush</surname><given-names>A</given-names></name><name><surname>Yogev</surname><given-names>Y</given-names></name><name><surname>Hod</surname><given-names>M</given-names></name></person-group>
<article-title>Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes</article-title>. <source>Diabet Med</source>
<year>2004</year>; <volume>21</volume>: <fpage>103</fpage>&#8211;<lpage>113</lpage>.<pub-id pub-id-type="pmid">14984444</pub-id></mixed-citation></ref><ref id="bibr11-1470320316653283"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Ning</surname><given-names>Y</given-names></name></person-group>
<article-title>Effect of dietary and lifestyle factors on the risk of gestational diabetes: Review of epidemiologic evidence</article-title>. <source>Am J Clin Nutr</source>
<year>2011</year>; <volume>94</volume> (<issue>6 Suppl</issue>): <fpage>1975S</fpage>-<lpage>1979S</lpage>.<pub-id pub-id-type="pmid">21613563</pub-id></mixed-citation></ref><ref id="bibr12-1470320316653283"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chu</surname><given-names>SY</given-names></name><name><surname>Callaghan</surname><given-names>WM</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><etal/></person-group>
<article-title>Maternal obesity and risk of gestational diabetes mellitus</article-title>. <source>Diabetes Care</source>
<year>2007</year>; <volume>30</volume>: <fpage>2070</fpage>&#8211;<lpage>2076</lpage>.<pub-id pub-id-type="pmid">17416786</pub-id></mixed-citation></ref><ref id="bibr13-1470320316653283"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Bao</surname><given-names>W</given-names></name><name><surname>Rong</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Genetic variants and the risk of gestational diabetes mellitus: A systematic review</article-title>. <source>Hum Reprod Update</source>
<year>2013</year>; <volume>19</volume>: <fpage>376</fpage>&#8211;<lpage>390</lpage>.<pub-id pub-id-type="pmid">23690305</pub-id></mixed-citation></ref><ref id="bibr14-1470320316653283"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lambrinoudaki</surname><given-names>I</given-names></name><name><surname>Vlachou</surname><given-names>SA</given-names></name><name><surname>Creatsas</surname><given-names>G</given-names></name></person-group>
<article-title>Genetics in gestational diabetes mellitus: Association with incidence, severity, pregnancy outcome and response to treatment</article-title>. <source>Curr Diabetes Rev</source>
<year>2010</year>; <volume>6</volume>: <fpage>393</fpage>&#8211;<lpage>399</lpage>.<pub-id pub-id-type="pmid">20879971</pub-id></mixed-citation></ref><ref id="bibr15-1470320316653283"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shaat</surname><given-names>N</given-names></name><name><surname>Groop</surname><given-names>L</given-names></name></person-group>
<article-title>Genetics of gestational diabetes mellitus</article-title>. <source>Curr Med Chem</source>
<year>2007</year>; <volume>14</volume>: <fpage>569</fpage>&#8211;<lpage>583</lpage>.<pub-id pub-id-type="pmid">17346148</pub-id></mixed-citation></ref><ref id="bibr16-1470320316653283"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Diez</surname><given-names>JJ</given-names></name><name><surname>Iglesias</surname><given-names>P</given-names></name></person-group>
<article-title>The role of the novel adipocyte-derived hormone adiponectin in human disease</article-title>. <source>Eur J Endocrinol</source>
<year>2003</year>; <volume>148</volume>: <fpage>293</fpage>&#8211;<lpage>300</lpage>.<pub-id pub-id-type="pmid">12611609</pub-id></mixed-citation></ref><ref id="bibr17-1470320316653283"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fruebis</surname><given-names>J</given-names></name><name><surname>Tsao</surname><given-names>TS</given-names></name><name><surname>Javorschi</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice</article-title>. <source>Proc Natl Acad Sci U S A</source>
<year>2001</year>; <volume>98</volume>: <fpage>2005</fpage>&#8211;<lpage>2010</lpage>.<pub-id pub-id-type="pmid">11172066</pub-id></mixed-citation></ref><ref id="bibr18-1470320316653283"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Renaldi</surname><given-names>O</given-names></name><name><surname>Pramono</surname><given-names>B</given-names></name><name><surname>Sinorita</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Hypoadiponectinemia: A risk factor for metabolic syndrome</article-title>. <source>Acta Med Indones</source>
<year>2009</year>; <volume>41</volume>: <fpage>20</fpage>&#8211;<lpage>24</lpage>.<pub-id pub-id-type="pmid">19258676</pub-id></mixed-citation></ref><ref id="bibr19-1470320316653283"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamauchi</surname><given-names>T</given-names></name><name><surname>Kamon</surname><given-names>J</given-names></name><name><surname>Waki</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity</article-title>. <source>Nat Med</source>
<year>2001</year>; <volume>7</volume>: <fpage>941</fpage>&#8211;<lpage>946</lpage>.<pub-id pub-id-type="pmid">11479627</pub-id></mixed-citation></ref><ref id="bibr20-1470320316653283"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kadowaki</surname><given-names>T</given-names></name><name><surname>Yamauchi</surname><given-names>T</given-names></name><name><surname>Kubota</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome</article-title>. <source>J Clin Invest</source>
<year>2006</year>; <volume>116</volume>: <fpage>1784</fpage>&#8211;<lpage>1792</lpage>.<pub-id pub-id-type="pmid">16823476</pub-id></mixed-citation></ref><ref id="bibr21-1470320316653283"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>WS</given-names></name><name><surname>Tsou</surname><given-names>PL</given-names></name><name><surname>Lee</surname><given-names>WJ</given-names></name><etal/></person-group>
<article-title>Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity</article-title>. <source>J Mol Med (Berl)</source>
<year>2003</year>; <volume>81</volume>: <fpage>428</fpage>&#8211;<lpage>434</lpage>.<pub-id pub-id-type="pmid">12750819</pub-id></mixed-citation></ref><ref id="bibr22-1470320316653283"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hara</surname><given-names>K</given-names></name><name><surname>Boutin</surname><given-names>P</given-names></name><name><surname>Mori</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population</article-title>. <source>Diabetes</source>
<year>2002</year>; <volume>51</volume>: <fpage>536</fpage>&#8211;<lpage>540</lpage>.<pub-id pub-id-type="pmid">11812766</pub-id></mixed-citation></ref><ref id="bibr23-1470320316653283"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Menzaghi</surname><given-names>C</given-names></name><name><surname>Ercolino</surname><given-names>T</given-names></name><name><surname>Di Paola</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome</article-title>. <source>Diabetes</source>
<year>2002</year>; <volume>51</volume>: <fpage>2306</fpage>&#8211;<lpage>2312</lpage>.<pub-id pub-id-type="pmid">12086965</pub-id></mixed-citation></ref><ref id="bibr24-1470320316653283"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>LL</given-names></name><name><surname>Kang</surname><given-names>XL</given-names></name><name><surname>Ran</surname><given-names>XJ</given-names></name><etal/></person-group>
<article-title>Associations between 45T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes</article-title>. <source>Clin Exp Pharmacol Physiol</source>
<year>2007</year>; <volume>34</volume>: <fpage>1287</fpage>&#8211;<lpage>1290</lpage>.<pub-id pub-id-type="pmid">17973869</pub-id></mixed-citation></ref><ref id="bibr25-1470320316653283"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beltcheva</surname><given-names>O</given-names></name><name><surname>Boyadzhieva</surname><given-names>M</given-names></name><name><surname>Angelova</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>The rs266729 single-nucleotide polymorphism in the adiponectin gene shows association with gestational diabetes</article-title>. <source>Arch Gynecol Obstet</source>
<year>2014</year>; <volume>289</volume>: <fpage>743</fpage>&#8211;<lpage>748</lpage>.<pub-id pub-id-type="pmid">24068295</pub-id></mixed-citation></ref><ref id="bibr26-1470320316653283"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>YL</given-names></name><name><surname>Fan</surname><given-names>YP</given-names></name><etal/></person-group>
<article-title>Association of adiponectin gene polymorphism 45TG with gestational diabetes mellitus diagnosed on the new IADPSG criteria, plasma adiponectin levels and adverse pregnancy outcomes</article-title>. <source>Clin Exp Med</source>
<year>2015</year>; <volume>15</volume>: <fpage>47</fpage>&#8211;<lpage>53</lpage>.<pub-id pub-id-type="pmid">24664457</pub-id></mixed-citation></ref><ref id="bibr27-1470320316653283"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hua</surname><given-names>P</given-names></name></person-group>
<article-title>Association of adiponectin polymorphism with the risk of gestational diabetes mellitus [article in Chinese]</article-title>. <source>Maternal Child Health Care China</source>
<year>2014</year>; <volume>29</volume>: <fpage>1742</fpage>&#8211;<lpage>1744</lpage>.</mixed-citation></ref><ref id="bibr28-1470320316653283"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>GH</given-names></name><name><surname>Kong</surname><given-names>LJ</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Association of adiponectin gene polymorphisms +45T/G with gestational diabetes mellitus and neonate birth weight [article in Chinese]</article-title>. <source>Zhonghua Yi Xue Za Zhi</source>
<year>2013</year>; <volume>93</volume>: <fpage>3770</fpage>&#8211;<lpage>3772</lpage>.<pub-id pub-id-type="pmid">24548395</pub-id></mixed-citation></ref><ref id="bibr29-1470320316653283"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name></person-group>
<article-title>Association between adiponectin polymorphism and gestational diabetes mellitus [article in Chinese]</article-title>. <source>Guangdong Med J</source>
<year>2006</year>; <volume>27</volume>: <fpage>1822</fpage>&#8211;<lpage>1824</lpage>.</mixed-citation></ref><ref id="bibr30-1470320316653283"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Low</surname><given-names>CF</given-names></name><name><surname>Mohd Tohit</surname><given-names>ER</given-names></name><name><surname>Chong</surname><given-names>PP</given-names></name><etal/></person-group>
<article-title>Adiponectin SNP45TG is associated with gestational diabetes mellitus</article-title>. <source>Arch Gynecol Obstet</source>
<year>2011</year>; <volume>283</volume>: <fpage>1255</fpage>&#8211;<lpage>1260</lpage>.<pub-id pub-id-type="pmid">20552210</pub-id></mixed-citation></ref><ref id="bibr31-1470320316653283"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Takhshid</surname><given-names>MA</given-names></name><name><surname>Haem</surname><given-names>Z</given-names></name><name><surname>Aboualizadeh</surname><given-names>F</given-names></name></person-group>
<article-title>The association of circulating adiponectin and + 45 T/G polymorphism of adiponectin gene with gestational diabetes mellitus in Iranian population</article-title>. <source>J Diabetes Metab Disord</source>
<year>2015</year>; <volume>14</volume>: <fpage>30</fpage>.<pub-id pub-id-type="pmid">25909078</pub-id></mixed-citation></ref><ref id="bibr32-1470320316653283"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name></person-group>
<article-title>The relationship between human adiponectin gene polymorphism and gestational diabetes mellitus in Guangxi Zhuang [article in Chinese]</article-title>. <source>J Chin Physician</source>
<year>2014</year>; <volume>16</volume>: <fpage>1221</fpage>&#8211;<lpage>1223</lpage>.</mixed-citation></ref><ref id="bibr33-1470320316653283"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>DerSimonian</surname><given-names>R</given-names></name><name><surname>Laird</surname><given-names>N</given-names></name></person-group>
<article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source>
<year>1986</year>; <volume>7</volume>: <fpage>177</fpage>&#8211;<lpage>188</lpage>.<pub-id pub-id-type="pmid">3802833</pub-id></mixed-citation></ref><ref id="bibr34-1470320316653283"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Egger</surname><given-names>M</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source>
<year>1997</year>; <volume>315</volume>: <fpage>629</fpage>&#8211;<lpage>634</lpage>.<pub-id pub-id-type="pmid">9310563</pub-id></mixed-citation></ref></ref-list></back></article>